The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
Nokia Oyj
OMXH:NOKIA
|
FI |
|
Farmers National Banc Corp
NASDAQ:FMNB
|
US |
|
P
|
Philip Morris International Inc
XMUN:4I1
|
US |
|
Dorman Products Inc
NASDAQ:DORM
|
US |
|
Westbury Bancorp Inc
OTC:WBBW
|
US |
|
N
|
Nutrien Ltd
F:N7T
|
CA |
|
S
|
Surteco Group SE
F:SUR
|
DE |
|
Vytrus Biotech SA
MAD:VYT
|
ES |
|
S
|
Starpharma Holdings Ltd
OTC:SPHRY
|
AU |
|
J
|
Johnson & Johnson
DUS:JNJ
|
US |
|
T
|
Tandy Leather Factory Inc
NASDAQ:TLF
|
US |
|
Wereldhave Belgium NV
XBRU:WEHB
|
BE |
|
S
|
Shinsung Delta Tech Co Ltd
KOSDAQ:065350
|
KR |
|
Piquadro SpA
MIL:PQ
|
IT |
|
Swiss Prime Site AG
OTC:SWPRF
|
CH |
|
E
|
Evoke PLC
OTC:EIHDF
|
GI |
|
Laureate Education Inc
NASDAQ:LAUR
|
US |
|
Heineken NV
F:HNK1
|
NL |
|
N
|
Nice Information & Telecommunication Inc
KOSDAQ:036800
|
KR |
|
Antofagasta PLC
LSE:ANTO
|
UK |
|
Vidrala SA
F:VIR
|
ES |
|
M
|
MFEC PCL
SET:MFEC
|
TH |
|
Azelis Group NV
LSE:0AA6
|
BE |
ANI Pharmaceuticals Inc (ANIP)’s 12-month stock price forecast through November 2027 has a consensus target of $104.04, implying 43% upside. The forecast is based on price targets from 11 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
ANIP is 104.04 USD with a low forecast of 85.85 USD and a high forecast of 127.05 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 8%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 35%. The projected CAGR for the next 5 years is 12%.
The compound annual growth rate for Operating Income over the next 8 years is 20%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 56%.
The compound annual growth rate for Net Income over the next 8 years is 23%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more